Publications by authors named "Elizabeth Ahern"

Claim this Profile
F
Factors that influence clinical trial participation for oncology patients in Australia: a scoping review.
Kyung Ha You, Zarnie Lwin, Elizabeth Ahern, David Wyld, Natasha Roberts

BMJ Open· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sacituzumab Govitecan in Patients with Relapsed/Refractory Advanced Head and Neck Squamous Cell Carcinoma: Results from the Phase II TROPiCS-03 Basket Study.
Loren Michel, Antonio Jimeno, Ammar Sukari, J Thaddeus Beck, Joanne Chiu, Elizabeth Ahern

Clin Cancer Res· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comprehensive humoral and cellular immune responses to COVID-19 vaccination in adults with cancer.
Amy Body, Luxi Lal, Sriganesh Srihari, C Raina MacIntyre, Jim Buttery, Elizabeth Stephanie Ahern

Vaccine· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evolving Practice and Outcomes in Grade 2 Glioma: Real-World Data from a Multi-Institutional Registry.
Lucy Gately, Katharine Drummond, Anthony Dowling, Iwan Bennett, Ronnie Freilich, Elizabeth Ahern

Cancers (Basel)· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improving Clinical Registry Data Quality via Linkage With Survival Data From State-Based Population Registries.
Samuel Smith, Kate Drummond, Anthony Dowling, Iwan Bennett, David Campbell, Elizabeth Ahern

JCO Clin Cancer Inform· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum: Translatability of findings from cynomolgus monkey to human suggests a mechanistic role for IL-21 in promoting immunogenicity to an anti-PD-1/IL-21 mutein fusion protein.
Mark A Kroenke, Marta Starcevic Manning, Christina L Zuch de Zafra, Xinwen Zhang, Kevin D Cook, Elizabeth Ahern

Front Immunol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Translatability of findings from cynomolgus monkey to human suggests a mechanistic role for IL-21 in promoting immunogenicity to an anti-PD-1/IL-21 mutein fusion protein.
Mark A Kroenke, Marta Starcevic Manning, Christina L Zuch de Zafra, Xinwen Zhang, Kevin D Cook, Elizabeth Ahern

Front Immunol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of sarcopenia and myosteatosis on survival outcomes for patients with head and neck cancer undergoing curative-intent treatment.
Elizabeth Ahern, Teresa Ellen Brown, Louise Campbell, Brett G M Hughes, Merrilyn Banks

Br J Nutr· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
From doctors to ancillary staff: Regional and metropolitan cancer workforce perceptions and distress resulting from COVID-19 pandemic adaptations.
Natasha A Roberts, Elizabeth Ahern, Anita Pelecanos, Harry Gasper, Bryan Chan

Semin Oncol· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rapid Protocol Development, Study Startup and Enrolment of a Prospective Study of COVID-19 Vaccination for Patients with Cancer: A Collaborative Approach.
Amy Body, Vivienne Milch, Lynda McSorley, Luxi Lal, Elizabeth Ahern

Vaccines (Basel)· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adult medulloblastoma in an Australian population.
Sagun Parakh, Amy Davies, Kerryn Westcott, Daniel Roos, Amal Abou-Hamden, Elizabeth Ahern

J Clin Neurosci· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Beyond standard data collection - the promise and potential of BRAIN (Brain tumour Registry Australia INnovation and translation registry).
Lucy Gately, Katharine Drummond, Mark Rosenthal, Rosemary Harrup, Anthony Dowling, Elizabeth Ahern

BMC Cancer· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Resilience and ongoing quality care for cancer clinical trials during COVID-19: Experience from a tertiary hospital in Australia.
Amy Ives, Tricia Pusztai, Jacqui Keller, Elizabeth Ahern, Bryan Chan

Asia Pac J Clin Oncol· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Factors that influence clinical trial participation by patients with cancer in Australia: a scoping review protocol.
Kyung Ha You, Zarnie Lwin, Elizabeth Ahern, David Wyld, Natasha Roberts

BMJ Open· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Scoping to analyze oncology trial participation in Australia.
Kyung Ha You, Elizabeth Ahern, David Wyld, Zarnie Lwin, Natasha Roberts

Semin Oncol· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selective Targeting of Protein Kinase C (PKC)-θ Nuclear Translocation Reduces Mesenchymal Gene Signatures and Reinvigorates Dysfunctional CD8 T Cells in Immunotherapy-Resistant and Metastatic Cancers.
Jenny Dunn, Robert D McCuaig, Abel H Y Tan, Wen Juan Tu, Fan Wu, Elizabeth Ahern

Cancers (Basel)· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Protocol for SARS-CoV-2 post-vaccine surveillance study in Australian adults and children with cancer: an observational study of safety and serological and immunological response to SARS-CoV-2 vaccination (SerOzNET).
Amy Body, Elizabeth Ahern, Luxi Lal, Karen Gillett, Hesham Abdulla

BMC Infect Dis· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
COVID-19 vaccinations for patients with cancer: many remain unvaccinated despite having priority in the vaccine rollout.
Amy Body, Elizabeth Ahern, Eva Segelov

Intern Med J· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author Correction: Targeting novel LSD1-dependent ACE2 demethylation domains inhibits SARS-CoV-2 replication.
Wen Juan Tu, Robert D McCuaig, Michelle Melino, Daniel J Rawle, Thuy T Le, Elizabeth Ahern

Cell Discov· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neoadjuvant immunotherapy for non-small cell lung cancer: right drugs, right patient, right time?
Elizabeth Ahern, Ben J Solomon, Rina Hui, Nick Pavlakis, Ken O'Byrne

J Immunother Cancer· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Semiqualitative research protocol to explore cancer care workforce perceptions of the health system response to COVID-19 preparations in Southeast Queensland, Australia.
Harry Gasper, Elizabeth Ahern, Natasha Roberts, Bryan Chan, Brett Hughes

BMJ Open· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting novel LSD1-dependent ACE2 demethylation domains inhibits SARS-CoV-2 replication.
Wen Juan Tu, Robert D McCuaig, Michelle Melino, Daniel J Rawle, Thuy T Le, Elizabeth Ahern

Cell Discov· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trends in epidemiology, treatment and molecular testing of metastatic colorectal cancer in a real-world multi-institution cohort study.
Anna Kuchel, Elizabeth Ahern, Stephanie Collins, Vicki Whitehall, Satomi Okano

Asia Pac J Clin Oncol· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
COVID-19 and the cancer care workforce: From doctors to ancillary staff.
Harry Gasper, Elizabeth Ahern, Natasha Roberts, Bryan Chan, Zarnie Lwin

Semin Oncol· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD155 on Tumor Cells Drives Resistance to Immunotherapy by Inducing the Degradation of the Activating Receptor CD226 in CD8 T Cells.
Matthias Braun, Amelia Roman Aguilera, Ashmitha Sundarrajan, Dillon Corvino, Kimberley Stannard, Elizabeth Ahern

Immunity· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis